WHWK: Notice of Proposed Sale of Common Stock
Whitehawk Therapeutics submitted a Form 144 notice covering proposed sales of Common Stock and Restricted Stock Units.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Whitehawk Therapeutics submitted a Form 144 notice covering proposed sales of Common Stock and Restricted Stock Units.
The filing lists 775,828 Restricted Stock Units with an entry date of 04/01/2026 and reports a prior sale of 5,100 shares on 03/02/2026 for $16,878.96.
Insights
Form 144 records proposed resale activity and a recent small open-market sale.
Form 144 is a regulatory notice used to report proposed sales by affiliates or insiders. The filing here lists 775,828 Restricted Stock Units dated 04/01/2026 and a reported sale of 5,100 shares on 03/02/2026 for $16,878.96. This reflects routine disclosure obligations rather than an executed large distribution.
Timing and exact planned methods for resale are not provided in the excerpt; subsequent filings may detail sale mechanics or confirm execution. Cash‑flow treatment is not specified in the provided excerpt.
Key Figures
Key Terms
Form 144 regulatory
Restricted Stock Units financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does WHWK's Form 144 disclose about proposed sales?
Does the Form 144 state who is selling WHWK securities?
Are the sale methods or proceeds destination shown in the WHWK excerpt?
AI-generated analysis. How Rhea-AI works. Not financial advice.